RSS Feed For (NASDAQ:GNBT)

GENEREX BIOTECH (NASDAQ:GNBT)

0.59 -0 (-0%)
GENEREX BIOTECH (NASDAQ:GNBT) Delayed :
Previous Close $0.59    52 Week High $1.14 
Open $0.61    52 Week Low $0.08 
Day High $0.61    P/E N/A 
Day Low $0.58    EPS $-0.26 
Volume 981,601       
More GNBT Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
HEB 7 AVII 6
NVAX 6 BCRX 6
CLDX 6 HEB 6
AVII 5 CVM 5
NVAX 5 BCRX 5
SVA 5 GSK 5
View All Friends, Peers and Foes

StreetInsider Reports on GNBT by Category

View All Comments Comments on recent GNBT articles

dianne
on Jan 25, 2010
at 06:58 PM
Gnbt This is a great company! A cure for Cancer and the U.S. won't approve it?
Article: Generex Biotech (GNBT) Announces Crave-NX Diet Spray To Be Available at 256 Duane's Locations
frank graus
on Jan 9, 2010
at 10:59 PM
gnbt/crave-nx just a small part of a bigger picture this company has so many different project in the works and crave-nx is just to fund the bigger picture get some now or miss the ship not the boat!
Article: Generex Biotech (GNBT) Announces Crave-NX Diet Spray To Be Available at 256 Duane's Locations
jonnal
on Dec 18, 2009
at 06:28 PM
this artical was updated nextday there were 0 of 49 relapse's in the Ae37 part of the trial arm compared to 5 of 71 in the comparative arm of the phase II trial. the treatment arm of the trial had 2 parts the Ae37 peptide and the other,a gp2 peptide
Article: Generex Biotech (GNBT) Presents Interim Phase II Immunotherapeutic Vaccine Results at SABCS
Nougatine1
on Dec 17, 2009
at 08:38 AM
YES They CAN.... All the best to AF...Cramer and The Street for this end of Year... AF...If you have some...You would can pay Champaign... P
Article: Generex MENA Supplies Products to New International Territories
Nougatine1
on Dec 15, 2009
at 04:07 AM
Malinda you are absolutely right... Malinda...I fully agree with your analysis... Thks for all...
Article: Generex Presents Encouraging Interim Results of Phase II Breast Cancer Study
View All Comments

Comments on GNBT


No comments are currently available.